Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Intangibles (2016 - 2025)

Iradimed (IRMD) has disclosed Intangibles for 13 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 9.2% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, up 9.2% year-over-year, with the annual reading at $3.4 million for FY2025, 9.2% up from the prior year.
  • Intangibles for Q4 2025 was $3.4 million at Iradimed, roughly flat from $3.4 million in the prior quarter.
  • The five-year high for Intangibles was $3.4 million in Q4 2025, with the low at $1.1 million in Q3 2021.
  • Average Intangibles over 5 years is $2.5 million, with a median of $2.7 million recorded in 2022.
  • The sharpest move saw Intangibles decreased 29.78% in 2021, then surged 155.15% in 2022.
  • Over 5 years, Intangibles stood at $1.1 million in 2021, then surged by 85.01% to $2.1 million in 2022, then grew by 21.73% to $2.5 million in 2023, then increased by 23.02% to $3.1 million in 2024, then rose by 9.2% to $3.4 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $3.4 million, $3.4 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.